Scotland · NHS Scotland MSAN
Paroxetine (Seroxat®) 20mg/10ml oral suspension
MSAN(2022)1 · Level 2 · issued 19 Jul 2022
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: to be discontinued in July 2022 | Discontinued | — |
| 1. Paroxetine (Seroxat®) 20mg/10ml oral suspension will be discontinued in July 2022. | Discontinued | — |
| review existing patients and for whom discontinuation of treatment is being considered | Discontinued | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.